Article Dans Une Revue Frontiers in Immunology Année : 2024

T4 apoptosis in the acute phase of SARS-CoV-2 infection predicts long COVID

Lucy Kundura

Résumé

Background: As about 10% of patients with COVID-19 present sequelae, it is important to better understand the physiopathology of so-called long COVID. Method: To this aim, we recruited 29 patients hospitalized for SARS-CoV-2 infection and, by Luminex ® , quantified 19 soluble factors in their plasma and in the supernatant of their peripheral blood mononuclear cells, including inflammatory and anti-inflammatory cytokines and chemokines, Th1/Th2/Th17 cytokines, and endothelium activation markers. We also measured their T4, T8 and NK differentiation, activation, exhaustion and senescence, T cell apoptosis, and monocyte subpopulations by flow cytometry. We compared these markers between participants who developed long COVID or not one year later. Results: None of these markers was predictive for sequelae, except programmed T4 cell death. T4 lymphocytes from participants who later presented long COVID were more apoptotic in culture than those of sequelae-free participants at Month 12 (36.9 ± 14.7 vs. 24.2 ± 9.0%, p = 0.016). Conclusions: Our observation raises the hypothesis that T4 cell death during the acute phase of SARS-CoV-2 infection might pave the way for long COVID. Mechanistically, T4 lymphopenia might favor phenomena that could cause sequelae, including SARS-CoV-2 persistence, reactivation of other viruses, autoimmunity and immune dysregulation. In this scenario, inhibiting T cell apoptosis, for instance, by caspase inhibitors, could prevent long COVID.

Fichier principal
Vignette du fichier
fimmu-14-1335352.pdf (1.08 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-05527034 , version 1 (25-02-2026)

Licence

Identifiants

Citer

Renaud Cezar, Lucy Kundura, Sonia André, Claire Lozano, Thierry Vincent, et al.. T4 apoptosis in the acute phase of SARS-CoV-2 infection predicts long COVID. Frontiers in Immunology, 2024, 14, ⟨10.3389/fimmu.2023.1335352⟩. ⟨hal-05527034⟩
24 Consultations
22 Téléchargements

Altmetric

Partager

  • More